Find your next paid study

Apriligen, Inc.NCT07476183

~$150 – $4,200

Actual pay is set by the research site.

Development of a cfDNA 5mC/5hmC-based Epigenetic Biomarker Panel to Identify Determinants of Response In VEGF/EGFR-targeted Therapy for Metastatic Colorectal Cancer

The EpiDRIVE study aims to identify cfDNA-based epigenetic determinants of response in metastatic colorectal cancer (mCRC) patients treated with EGFR- or VEGF-…

CRC (Colorectal Cancer)

City of Hope Medical CenterNCT07224841

Actual pay is set by the research site.

Phase 4

The Impact of Upper Gastrointestinal Dysmotility on Aspiration-associated Symptoms

The hypothesis of this study is that esophageal and gastric dysmotility increase the risk of developing aspiration-associated symptoms in children with neurolo…

Esophageal Motility DisordersGastric Motor DysfunctionAspiration Pneumonia+1 more

Boston Children's HospitalNCT05455359

~$25 – $1,000

Actual pay is set by the research site.

Phase 2

A Phase 2, Open-Label Study to Evaluate the Safety and Efficacy of Intravesical Instillation of TARA-002 in Adults With High-Grade Non-Muscle Invasive Bladder Cancer

TARA-002-101-Ph2 is an open-label study to investigate the safety and efficacy of intravesical instillation of TARA-002 in adults 18 years of age or older with…

Non-muscle Invasive Bladder Cancer

Protara TherapeuticsNCT05951179

~$75 – $2,800

Actual pay is set by the research site.

Drug DiscontinuationSubstance Use DisordersEating Behavior Changes+1 more

Clinical and Neurobehavioral Changes With GLP-1 (Glucagon-like Peptide-1) Discontinuation

The goal of this clinical study with research procedures is to learn how stopping and restarting tirzepatide (a medication that helps regulate blood sugar and …

The University of Texas at DallasNCT07387796

Actual pay is set by the research site.

Neural and Affective Mechanisms Underlying Prospective Self-control Costs

Self-control failures are a universal challenge for healthy and clinical populations. Recent work suggests these failures may arise from excessive cognitive co…

Self-Control

NYU Langone HealthNCT05795179

~$10 – $1,125

Actual pay is set by the research site.

An Efficacy and Feasibility Trial of a Portable Near Infra-Red Hematoma Imager for Detection of Intracranial Hemorrhage in the Acute Care Setting

Traumatic Brain Injury (TBI) is a leading cause of death and disability among military personnel, Veterans, and civilians. One of the most dangerous complicati…

Traumatic Brain InjuryIntracranial HemorrhagesCombat Casualty Care+1 more

The Geneva FoundationNCT07338383

Actual pay is set by the research site.

The ADAPT Trial: Adapting Evidence-Based Obesity Interventions in Community Settings

Evidence-based obesity treatment is inaccessible to most children in the United States. This lack of access is a source of health inequity, whereby children fr…

Childhood Obesity

Vanderbilt University Medical CenterNCT06546696

Actual pay is set by the research site.

Psychomotor AgitationBehavioral Disorder

Peer Support Enhanced Behavioral Crisis Response Teams in the Emergency Department

The purpose of this study is to conduct a clinical trial that tests the acceptability, fidelity, and feasibility of a peer support modified intervention for ag…

Yale UniversityNCT06556069

Actual pay is set by the research site.

Evaluation of Ingestible Mini-pill for Gastrointestinal Regional Luminal Content Sampling

The purpose of this proof-of-concept study in humans is to determine if a noninvasive, ingestible device, called a "mini-pill", can collect gastrointestinal (G…

Gut Microbiota

Tufts UniversityNCT07220369

Actual pay is set by the research site.

Mitral Valve (MV) Regurgitation

Transventricular Off-pump Mitral Valve Repair (TRANSOM)

The purpose of this study is to assess the safety and effectiveness (usefulness) of an investigational technique used to repair the mitral valve for patients w…

Johns Hopkins UniversityNCT07726173

Actual pay is set by the research site.

Phase 2

Phase II Open-label Study of ARX788 (Anti-HER2 Antibody Drug Conjugate (ADC)) for Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer

This phase II trial tests how well ARX788 works in treating patients diagnosed with HER2-low, locally advanced unresectable or metastatic breast cancer. ARX788…

HER2 Low Breast CarcinomaTriple Negative Breast CancerHormone-receptor-positive Breast Cancer+1 more